WESTLAKE CORP WLK

Healthcare SIC 2860 - Industrial Organic Chemicals NAICS Manufacturing › Chemical Manufacturing › Basic Chemical Manufacturing › Other Basic Organic Chemical Manufacturing derived NYSE

Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases

Management's Discussion and Analysis of Financial Condition and Results of Operations

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Last close 64.56 2026-10-23
Market cap $8.25B 2026-06-30 share count
52-week range 56.33 - 124.23

Valuation FY2025 figures against the last close

P/S0.7x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield3.3%
Diluted EPS-11.70

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • United States
  • Other
  • Canada
  • Germany
  • Mexico
  • China
  • Brazil
  • Italy
  • France
Revenue by geography, 9 categories over 2 years. The same figures are in the table below. FY2025 United States, FY2025: 8B (71.2%) 71% United States Other, FY2025: 1.1B (9.7%) 10% Other Canada, FY2025: 777M (7.0%) 7% Canada Germany, FY2025: 583M (5.2%) 5% Germany Mexico, FY2025: 194M (1.7%) China, FY2025: 162M (1.5%) Brazil, FY2025: 153M (1.4%) Italy, FY2025: 144M (1.3%) France, FY2025: 125M (1.1%) FY2023 United States, FY2023: 9B (71.4%) 71% Other, FY2023: 1.3B (10.0%) 10% Canada, FY2023: 808M (6.4%) 6% Germany, FY2023: 602M (4.8%) 5% Mexico, FY2023: 217M (1.7%) China, FY2023: 220M (1.8%) Brazil, FY2023: 215M (1.7%) Italy, FY2023: 135M (1.1%) France, FY2023: 138M (1.1%)
Region FY2025FY2023
United States $7.95B $8.96B
Other $1.08B $1.26B
Canada $777.0M $808.0M
Germany $583.0M $602.0M
Mexico $194.0M $217.0M
China $162.0M $220.0M
Brazil $153.0M $215.0M
Italy $144.0M $135.0M
France $125.0M $138.0M

As the company reported it, from the “Segment and Geographic Information (Geographic Information for Sales to External Customers and Long-lived Assets) (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $11.17B$12.14B$12.55B$15.79B$11.78B$7.50B$8.12B$8.63B$8.04B$5.08B
Cost of revenue $10.36B$10.19B$10.33B$11.72B$8.28B$6.48B$6.86B$6.65B$6.28B$4.09B
Gross profit $813.0M$1.96B$2.22B$4.07B$3.50B$1.02B$1.26B$1.99B$1.76B$983.0M
SG&A $900.0M$874.0M$865.0M$835.0M$551.0M$449.0M$458.0M$445.0M$399.0M$258.0M
Operating income -$1.58B$875.0M$729.0M$3.05B$2.80B$429.0M$656.0M$1.41B$1.23B$583.0M
Interest expense $171.0M$159.0M$165.0M$177.0M$176.0M$142.0M$124.0M$126.0M$159.0M$79.0M
Pre-tax income -$1.60B$938.0M$700.0M$2.95B$2.68B$331.0M$570.0M$1.33B$1.08B$558.0M
Income tax $126.0M$291.0M$178.0M$649.0M$607.0M$42.0M$108.0M$300.0M$258.0M$138.0M
Net income -$1.51B$602.0M$479.0M$2.25B$2.02B$330.0M$421.0M$996.0M$1.30B$399.0M
EPS, basic -11.704.663.7317.4615.662.573.267.6610.053.07
EPS, diluted -11.704.643.7017.3415.582.563.257.6210.003.06
Shares, diluted (wtd. avg.) 128.3M129.2M128.6M128.8M128.7M128.1M128.8M130.0M129.5M130.0M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $2.72B$2.92B$3.32B$2.25B$1.94B$1.34B$750.0M$775.0M$1.55B$646.0M
Short-term investments —————————$0
Receivables $1.23B$1.31B$1.39B$1.65B$1.74B$1.08B$938.0M$952.0M$961.0M$810.0M
Inventory $1.65B$1.70B$1.62B$1.87B$1.41B$918.0M$936.0M$1.01B$900.0M$801.0M
Total current assets $6.22B$6.21B$6.61B$5.97B$5.26B$3.48B$2.74B$2.84B$3.46B$2.41B
Property, plant and equipment $8.61B$8.63B$8.52B$8.48B$7.61B$6.92B$6.91B$6.59B$6.41B$6.42B
Goodwill $1.31B$2.03B$2.04B$2.16B$2.02B$1.08B$1.07B$1.00B$1.01B$947.0M
Other intangibles $743.0M$820.0M$910.0M$993.0M$1.08B$444.0M—$525.0M$616.0M$611.0M
Total assets $19.96B$20.75B$21.04B$20.55B$18.46B$13.84B$13.26B$11.60B$12.08B$10.89B
Accounts payable $783.0M$851.0M$877.0M$889.0M$879.0M$536.0M$473.0M$507.0M$600.0M$496.0M
Short-term debt $497.0M$6.0M$299.0M$0$269.0M$0—$0$710.0M$0
Total current liabilities $2.77B$2.22B$2.79B$2.30B$2.34B$1.36B$1.24B$1.18B$1.97B$1.18B
Long-term debt $5.09B$4.56B$4.61B$4.88B$4.91B$3.57B$3.44B$2.67B$3.13B$3.68B
Total liabilities $10.67B$9.71B$10.27B$10.09B$9.93B$7.26B$6.86B$5.53B$6.71B$7.00B
Retained earnings $8.70B$10.48B$10.14B$9.88B$7.81B$5.94B$5.76B$5.48B$4.61B$3.41B
Total equity $8.79B$10.53B$10.76B$10.46B$8.53B$6.58B$6.40B$6.08B$5.37B$3.89B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $465.0M$1.31B$2.34B$3.40B$2.39B$1.30B$1.30B$1.41B$1.53B$867.0M
Depreciation and amortisation $1.18B$1.11B$1.10B$1.06B$840.0M$773.0M$713.0M$641.0M$601.0M$378.0M
Stock-based compensation $41.0M$41.0M$43.0M$36.0M$31.0M$29.0M$25.0M$22.0M$23.0M$14.0M
Capital expenditure $995.0M$1.01B$1.03B$1.11B$658.0M$525.0M$787.0M$702.0M$577.0M$629.0M
Investing cash flow -$1.22B-$1.00B-$1.04B-$2.48B-$3.21B-$509.0M-$1.95B-$754.0M-$652.0M-$2.56B
Financing cash flow $530.0M-$650.0M-$245.0M-$587.0M$1.44B-$216.0M$630.0M-$1.43B$6.0M$1.69B
Dividends paid $272.0M$264.0M$221.0M$169.0M$145.0M$137.0M$132.0M$120.0M$103.0M$97.0M
Buybacks $63.0M$60.0M$23.0M$101.0M$30.0M$54.0M$30.0M$106.0M$0$67.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001262823-26-000016.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -5B 0 5B 10B 15B 20B Revenue, FY2016: 5.1B Gross profit, FY2016: 983M Net income, FY2016: 399M Revenue, FY2017: 8B Gross profit, FY2017: 1.8B Net income, FY2017: 1.3B Revenue, FY2018: 8.6B Gross profit, FY2018: 2B Net income, FY2018: 996M Revenue, FY2019: 8.1B Gross profit, FY2019: 1.3B Net income, FY2019: 421M Revenue, FY2020: 7.5B Gross profit, FY2020: 1B Net income, FY2020: 330M Revenue, FY2021: 11.8B Gross profit, FY2021: 3.5B Net income, FY2021: 2B Revenue, FY2022: 15.8B Gross profit, FY2022: 4.1B Net income, FY2022: 2.2B Revenue, FY2023: 12.5B Gross profit, FY2023: 2.2B Net income, FY2023: 479M Revenue, FY2024: 12.1B Gross profit, FY2024: 2B Net income, FY2024: 602M Revenue, FY2025: 11.2B Gross profit, FY2025: 813M Net income, FY2025: -1.5B FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $5.08B $8.04B $8.63B $8.12B $7.50B $11.78B $15.79B $12.55B $12.14B $11.17B
Gross profit $983.0M $1.76B $1.99B $1.26B $1.02B $3.50B $4.07B $2.22B $1.96B $813.0M
Net income $399.0M $1.30B $996.0M $421.0M $330.0M $2.02B $2.25B $479.0M $602.0M -$1.51B

Recent filings and events

  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Regulation FD disclosure Item 7.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Officer or director change Item 5.02
  • Regulation FD disclosure Item 7.01
  • Other event Item 8.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $24.02B — -5.2%
LYB LyondellBasell Industries N.V. $21.47B — -9.7%
NEU NEWMARKET CORP $8.01B 19.6x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.65B 42.0x 3.5%
REX REX AMERICAN RESOURCES Corp $1.32B 15.9x 1.2%
GPRE Green Plains Inc. $979.9M — 16.0%
WLKP Westlake Chemical Partners LP $745.5M — 2.7%
GEVO Gevo, Inc. $286.8M — 849.3%